PYOTT DAVID E I bought TARS
September 15, 2026 · Form 4 insider transaction
PYOTT DAVID E I bought 201 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
201
Price
N/A
Total value
N/A
InsiderPYOTT DAVID E I
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after9,575
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.; Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares.